- Brazil has approved the use of the Pfizer COVID-19 vaccine for children aged 3 to 5 years old.
- The decision was made by the country's health regulatory agency, Anvisa, following positive evaluations of safety and efficacy.
- This approval makes Brazil one of the first countries in Latin America to authorize vaccination for this younger age group.
- The vaccination campaign for young children is expected to begin soon, aiming to protect this vulnerable population.
- Health authorities emphasize the importance of vaccinating children to curb the spread of COVID-19 and prevent severe cases.
Related